Selectin Blocker Market: Introduction
Non-steroidal anti-inflammatory drugs hold a major revenue share of selectin blocker market because of better efficacy. Based on prescription, clinician prescribed drugs dominate the selectin blocker market as compared to over the counter drugs.
Oral route of administration holds more revenue share in selectin blocker market whereas, intravenous route of administration is expected to observe steady growth during the forecast period. Among indication type, chronic obstructive pulmonary diseases generate highest revenue share in selectin blocker market followed by cancer.
Hospital pharmacies is the largest distribution channel followed by retail pharmacies in the selectin blocker market. Online pharmacies are expected to have significant growth during the forecast period with an increased rate of adoption among the general population.
Get a Sample PDF Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12468
Selectin Blocker Market: Drivers and Restraints
The significant number of candidates under clinical trial is expected to drive selectin blocker market growth during the forecast period. For instance, a drug named Bimosiamose by Encysive Pharmaceuticals and Revotar Biopharmaceuticals is a currently leading candidate of selectin blocker market.
Demand for the drug with better efficacy and fewer side-effects will propel the demand for selectin blocker market during the forecast period. The rise in the prevalence of inflammatory reactions increases the demand for selectin blocker market.
Increasing geriatric population boosts selectin blocker market growth. Stringent regulatory policies for drug approval challenge selectin blocker market growth. Discovery of generic and biosimilar tend to hinder the growth of selectin blocker market.
Ask to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-12468
Selectin Blocker Market Segmentation:
Drug Type
- Anti-inflammatory Biologics
- Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
Prescription Type
- Prescribed
- Over the counter
Administration
- Oral
- Intravenous
Indication
- Prescribed
- Over the counter
Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Drug stores
- Online pharmacies
Selectin Blocker Market: Key Market Participants
Major players in selectin blocker market include –
- Pfizer Inc.
- AbbVie Inc.
- GlaxoSmithKline plc.
- F. Hoffmann-La Roche AG
- Merck and Co. Inc.
- Amgen Inc.
- AstraZeneca PLC.
- Eli Lily and Company
- Johnson and Johnson Inc.
- Novartis AG
- Sanofi S.A.
- Selexys Pharmaceuticals
- GlycoMimetics Inc.
- Cantex Pharmaceuticals
- ParinGenix Inc.
- ProtoKinetix Inc.
- Encysive pharmaceuticals Inc.
- Revotar Biopharmaceuticals AG
- Cytel Inc.
Buy this Report Now: https://www.futuremarketinsights.com/checkout/12468
Selectin Blocker Market: Region-wise Outlook
North America will continue to dominate the selectin blocker market during the forecast period with high rate of approvals and commercialization in the region. Increase in investment towards research and development activities will propel selectin blocker market to grow in the North America region.
Europe is expected to have significant growth in the coming decade with increased awareness and treatment-seeking rates in the selectin blocker market. Asia-Pacific is lucrative for market growth with a rise in the number of domestic players in the region in the coming decade.
Asia-pacific region has a high prevalence rate of COPD which leads to rise in patient population creating demand for selectin blocker market growth. Middle East and Africa are untapped region with very less healthcare spending in selectin blocker market.
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs